TELA Bio Stock

TELA Bio EBIT

The EBIT of TELA Bio (TELA) as of Aug 6, 2026 is -33.36 M USD. In the previous year, EBIT was -32.70 M USD — a change of 2.02% (lower).

EBIT

-33.36 MUSD

YoY

2.02%

Last updated:

In 2026, TELA Bio's EBIT was -33.36 M USD, a 2.02% increase from the -32.70 M USD EBIT recorded in the previous year.

The TELA Bio EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2021
-29.68 base
Jan 1, 2022
-40.25 base
Jan 1, 2023
-41.61 base
Jan 1, 2024
-32.70 base
Jan 1, 2025
-33.36 base
Jan 1, 2026 (e)
11.93 base
Jan 1, 2027 (e)
13.17 base
Jan 1, 2028 (e)
14.70 base
YEAREBIT (M USD)
2028 est 14.70
2027 est 13.17
2026 est 11.93
2025 -33.36
2024 -32.70
2023 -41.61
2022 -40.25
2021 -29.68
2020 -25.23
2019 -18.82
2018 -19.29
2017 -16.78
Access this data via the Eulerpool API

TELA Bio Revenue

TELA Bio Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
29.46 M USD
-29.68 M USD
-33.28 M USD
Jan 1, 2022
41.42 M USD
-40.25 M USD
-44.30 M USD
Jan 1, 2023
58.45 M USD
-41.61 M USD
-46.66 M USD
Jan 1, 2024
69.30 M USD
-32.70 M USD
-37.84 M USD
Jan 1, 2025
80.28 M USD
-33.36 M USD
-38.83 M USD
Jan 1, 2026 (e)
86.71 M USD
11.93 M USD
-28.62 M USD
Jan 1, 2027 (e)
95.73 M USD
13.17 M USD
-23.53 M USD
Jan 1, 2028 (e)
106.83 M USD
14.70 M USD
-17.03 M USD

TELA Bio Margins

TELA Bio stock margins

The TELA Bio margin analysis displays the gross margin, EBIT margin, as well as the profit margin of TELA Bio. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for TELA Bio.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
63.85 %
-100.73 %
-112.94 %
Jan 1, 2022
65.30 %
-97.17 %
-106.95 %
Jan 1, 2023
68.62 %
-71.19 %
-79.83 %
Jan 1, 2024
67.08 %
-47.18 %
-54.60 %
Jan 1, 2025
67.69 %
-41.55 %
-48.37 %
Jan 1, 2026 (e)
67.69 %
13.76 %
-33.01 %
Jan 1, 2027 (e)
67.69 %
13.76 %
-24.58 %
Jan 1, 2028 (e)
67.69 %
13.76 %
-15.94 %

TELA Bio Stock analysis

What does TELA Bio do? TELA Bio Inc is an American medical technology company that specializes in the development and manufacture of innovative surgical implants. The history of this company began in 2012 when a group of experienced bioengineers and medical professionals decided to develop a better surgical tissue replacement material. The idea was to create a product that not only supports the healing process but is also safe, durable, and easy to handle. Over the years, TELA Bio has successfully implemented the business model of complete vertical integration, which means that the company takes care of everything from research and development to production, distribution, and marketing of its products. This allows the company to build closer relationships with its customers and improve the quality of its products by addressing the needs and requirements of its users. The core business of TELA Bio focuses on a wide range of surgical tissue replacement materials specifically designed for plastic and reconstructive surgery, hernia repair, and wound healing. These products are characterized by their high biocompatibility, strength, and flexibility, and provide a safe and effective solution for a variety of medical applications. Key products offered by TELA Bio include the OviTex® product family, which includes surgical mesh materials for supporting wound healing in hernia repairs and abdominal surgeries, as well as tissue replacement materials for breast reconstruction after mastectomy. These products are known for their high biocompatibility and ability to integrate into the surrounding tissue and restore natural tissue structures. In addition, TELA Bio also offers the TELADERM®-DH product, specifically developed for wound healing in diabetes patients. This product consists of a tissue replacement material that supports skin repair and reduces the risk of infection, particularly in patients with poorly healing wounds. Overall, TELA Bio has developed a wide range of products tailored to the needs of modern medicine. The company is focused on improving the quality of medical care and providing innovative solutions for surgical wound healing. With its successful implementations in research, production, and distribution, TELA Bio is well-positioned to continue growing and solidify its position as a leading provider of medical implants. TELA Bio is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing TELA Bio's EBIT

TELA Bio's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of TELA Bio's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

TELA Bio's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in TELA Bio’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about TELA Bio stock

EBIT of TELA Bio is -33.36 M USD in 2026.

EBIT of TELA Bio changed from -32.70 M USD to -33.36 M USD, representing a 2.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT TELA Bio since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's TELA Bio historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — TELA Bio

All Key Metrics — TELA Bio